Centre for Primary Health Care Research, Region Skåne and Lund University
Malmö, Skåne County, 20502, Sweden
NCT Number: NCT01420198
An increasing proportion of Sweden's population comprises non-European immigrants, who constitute a high risk-population for T2D. Numbering almost 9,000 individuals, Iraqi citizens represent the largest immigrant group in Malmoe and are identified as a risk group for Type 2 Diabetes (T2D) in whom genetic and lifestyle factors probably play significant roles in the development of T2D.
Several studies have shown that adoption of an active lifestyle by at-risk individuals dramatically reduces the risk of T2D. However, there are currently no established methods for providing support to high-risk individuals from different cultural and social backgrounds to help them adopt beneficial lasting lifestyle changes. Instead of just waiting for Iraqi high-risk individuals to develop T2D, this project will implement and assess lifestyle intervention programs aimed at reducing the risk of developing T2D and tailored to individuals with a different social and cultural background.
The study thus seeks to optimize preventive action in health care and aims to facilitate the adoption of permanent changes in lifestyle in high-risk patients, taking account of cultural and social barriers.
Since T2D is associated with a sedentary lifestyle and develops earlier in men than women and an average 10 years earlier in immigrants from the Middle East than in native Swedes, it is crucial to study pathogenic mechanisms triggering T2D development in relation to sex, lifestyle and ethnic background. The results will provide the basis for deciding how health care providers can actively work to prevent T2D and other lifestyle-associated diseases in this high-risk population that has not been studied before.
Looking for future studies?
Notify Me30 year–75 year
All sexes
Interventional
Not applicable
Malmö, Skåne County, 20502, Sweden
In this randomized controlled trial, 308 participants (born in Iraq, living in Malmö, Sweden and at high risk of type 2 diabetes) will be allocated to either a culturally adapted intervention or a control group. The intervention will consist of 10 group counseling sessions focusing on diet, physical activity and behavioral change over 6 months, and the offer of exercise sessions. Cultural adaptation includes gender-specific exercise sessions, and counseling by a health coach community member. The control group will receive the information about healthy lifestyle habits provided by the primary health care center. The primary outcome is change in fasting glucose level. Secondary outcomes are changes in body mass index, insulin sensitivity,physical activity, food habits and health-related quality of life. Measurements will be taken at baseline, after 3 and 6 months. Data will be analyzed by the intention-to-treat approach. The cost-effectiveness during the trial period and over the longer term will be assessed by simulation modeling from patient, health care and societal perspectives.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Increased physical activity and improved food habits
Time frame: 4 months
measured by study nurses
Time frame: 4 months
self-reported
Time frame: 4 month
from food records
Time frame: 4 month
The effectiveness will be measured as change in health related quality in life measures as Quality adjusted life years (QALY)
Time frame: 4 month
fasting glucose, 2-hr glucose
Time frame: 4 month
Time frame: 4 month
insulin sensitivity index and disposition index
Time frame: 4 month
LDL, HDL, trilycerides
Time frame: 4 month
systolic and diastolic
Region Skane
Other
A Middle Eastern Immigrant Population At-risk for Diabetes; Contributing Risk Factors and the Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study.
Acronym: MEDIM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04931836
Behavior, Body Weight
Minneapolis, Minnesota, United States
View Trial DetailsNCT05174078
Body Weight, Cardiovascular Diseases
Akron, Ohio, United States
View Trial DetailsNCT06535295
Behavior, Body Weight
Istanbul, Kaguthane, Turkey (Türkiye)
View Trial DetailsNCT02498002
Behavior, Body Weight
Bath, Somerset, United Kingdom
View Trial Details